1. 53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB). (4th August 2020) Authors: Lin, Nancy; Murthy, Rashmi; Anders, Carey; Borges, Virginia; Hurvitz, Sara; Loi, Sherene; Abramson, Vandana; Bedard, Philippe; Oliveira, Mafalda; Zelnack, Amelia; DiGiovanna, Michael; Bachelot, Thomas; Chien, A Jo; O'Regan, Ruth; Wardley, Andrew; Mueller, Volkmar; Carey, Lisa; McGoldrick, Suzanne... Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 2 Page Start: ii11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benchmarks for Academic Oncology Faculty. Issue 3 (March 2021) Authors: Anthony, Lowell; Atweh, George; Bhatia, Ravi; Carey, Lisa A.; Chang, Jenny C.; Edelman, Martin J.; Kantoff, Philip W.; Markham, Merry Jennifer; Messersmith, Wells; Nelson, Edward L.; Oettel, Kurt; O'Regan, Ruth; Verschraegen, Claire F.; Vose, Julie M. Journal: JCO oncology practice Issue: Volume 17:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Issue 6 (12th June 2016) Authors: Li, Xiaoxian (Bill); Krishnamurti, Uma; Bhattarai, Shristi; Klimov, Sergey; Reid, Michelle D.; O'Regan, Ruth; Aneja, Ritu Journal: American journal of clinical pathology Issue: Volume 145:Issue 6(2016) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018) Authors: Di Leo, Angelo; Johnston, Stephen; Lee, Keun Seok; Ciruelos, Eva; Lønning, Per E; Janni, Wolfgang; O'Regan, Ruth; Mouret-Reynier, Marie-Ange; Kalev, Dimitar; Egle, Daniel; Csőszi, Tibor; Bordonaro, Roberto; Decker, Thomas; Tjan-Heijnen, Vivianne C G; Blau, Sibel; Schirone, Alessio; Weber, Denis; ... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Determining the impact of US mammography screening guidelines on patient survival in a predominantly African American population treated in a public hospital during 2008. Issue 3 (1st August 2012) Authors: Habtes, Imnett; Friedman, Danielle; Raskind‐Hood, Cheryl; Adams, Kathleen; Becker, Edmund R.; D'Orsi, Carl; Birdsong, George; Gundry, Kathleen; O'Regan, Ruth; Gabram, Sheryl G. A. Journal: Cancer Issue: Volume 119:Issue 3(2013) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. (January 2018) Authors: Miller-Kleinhenz, Jasmine; Guo, Xiangxue; Qian, Weiping; Zhou, Hongyu; Bozeman, Erica N.; Zhu, Lei; Ji, Xin; Wang, Y.Andrew; Styblo, Toncred; O'Regan, Ruth; Mao, Hui; Yang, Lily Journal: Biomaterials Issue: Volume 152(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Implementation of a chemotherapy stewardship process. (4th July 2020) Authors: Hennes, Emily R; Reed, Michael; Mably, Mary; Jared, Jason; Bergsbaken, Jason J; Deming, Dustin; Callander, Natalie; O'Regan, Ruth Journal: American journal of health-system pharmacy Issue: Volume 77:Number 15(2020) Page Start: 1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. (20th December 2012) Authors: Mitri, Zahi; Constantine, Tina; O'Regan, Ruth Other Names: Saba Nabil F. Academic Editor. Journal: Chemotherapy research and practice Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. (July 2014) Authors: Paplomata, Elisavet; O'Regan, Ruth Journal: Therapeutic advances in medical oncology Issue: Volume 6:Number 4(2014:Jul.) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗